Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comparing trajectories of cognitive functioning in treatment-resistant and non-resistant depression: a multicentre linear mixed-effects analysis.

BACKGROUND Impaired cognitive functioning is a severe symptom in major depressive disorder (MDD). Recent evidence suggests it may be a central characteristic in its treatment resistant form (TRD), potentially constituting a clinical marker for treatment resistance and a target amenable to intervention. To date, cogniti...

V. T. Wahner, T. Lange, Inga Stonner et al. · 0 citations
Open access Sep 2026

708. From molecules to meaning: metabolomic and transcriptomic pathways to overcoming treatment resistance

Abstract Background Treatment resistance remains a major barrier to improving outcomes in severe psychiatric disorders, reflecting substantial biological heterogeneity that is not captured by symptom-based diagnosis alone. Emerging multi-omics approaches—particularly metabolomic profiling combined with transcriptome-in...

B. Baune · 0 citations
Review Open access Sep 2026

Pharmaco-multiomics in major depressive disorder: a narrative review and proposed translational framework for difficult-to-treat and treatment-resistant depression

Background Antidepressant prescribing in major depressive disorder (MDD) remains dominated by sequential trial and error, particularly when illness becomes difficult to treat (DTD) or meets conventional treatment-resistant depression (TRD) criteria. Objective This narrative review evaluates pharmacogenomics (PGx), ther...

B. Baune · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.